Abstract
Since the turn of the millennium, the epidemiology of Clostridium difficile infection (CDI) has continued to challenge. Over the last decade there has been a growing awareness that improvements to surveillance are needed. The increasing rate of CDI and emergence of ribotype 027 precipitated the implementation of mandatory national surveillance of CDI in the UK. Changes in clinical presentation, severity of disease, descriptions of new risk factors and the occurrence of outbreaks all emphasised the importance of early diagnosis and surveillance.
However a lack of consensus on case definitions, clinical guidelines and optimal laboratory diagnostics across Europe has lead to the underestimation of CDI and impeded comparison between countries. These inconsistencies have prevented the true burden of disease from being appreciated.
Acceptance that a multi-country surveillance programme and optimised diagnostic strategies are required not only to detect and control CDI in Europe, but for a better understanding of the epidemiology, has built the foundations for a more robust, unified surveillance. The concerted efforts of the European Centre for Disease Prevention and Control (ECDC) CDI networks, has lead to the development of an over-arching long-term CDI surveillance strategy for 2014–2020. Fulfilment of the ECDC priorities and targets will no doubt be challenging and will require significant investment however the hope is that both a national and Europe-wide picture of CDI will finally be realised.
For surveillance systems to be useful, they must adapt to the changing environment in which they operate and accommodate emerging public health requirements that were not conceived previously.
Joseph S. Lombardo and David L. Buckeridge
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alcala L, Martin A, Marin M et al (2012) The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem? Clin Microbiol Infect 18(7):E204–E213. https://doi.org/10.1111/j.1469-0691.2012.03883.x
Barbut F, Corthier G, Charpak Y et al (1996) Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study. Arch Intern Med 156(13):1449–1454
Barbut F, Delmee M, Brazier JS et al (2003) A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin Microbiol Infect 9(10):989–996
Barbut F, Mastrantonio P, Delmee M et al (2007) Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 13(11):1048–1057. https://doi.org/10.1111/j.1469-0691.2007.01824.x
Bauer MP, Veenendaal D, Verhoef L et al (2009) Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands. Clin Microbiol Infect 15(12):1087–1092. https://doi.org/10.1111/j.1469-0691.2009.02853.x
Bauer MP, Notermans DW, Van Benthem BH et al (2011) Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377(9759):63–73. https://doi.org/10.1016/s0140-6736(10)61266-4
Cassini A, Plachouras D, Eckmanns T et al (2016) Burden of six healthcare-associated infections on European population health: estimating incidence-based disability-adjusted life years through a population prevalence-based modelling study. PLoS Med 13(10):e1002150. https://doi.org/10.1371/journal.pmed.1002150
Davies KA, Longshaw CM, Davis GL et al (2014) Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis 14(12):1208–1219. https://doi.org/10.1016/S1473-3099(14)70991-0
Delmee M (2001) Laboratory diagnosis of Clostridium difficile disease. Clin Microbiol Infect 7(8):411–416
Duerden BI (2011) Contribution of a government target to controlling Clostridium difficile in the NHS in England. Anaerobe 17(4):175–179. https://doi.org/10.1016/j.anaerobe.2010.12.004
Department of Health and Health Protection Agency (2008) Clostridium difficile infection: how to deal with the problem
ECDC (2013a) European Centre for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. Stockholm
ECDC (2013b) European Centre for Disease Prevention and Control. Long-term surveillance strategy 2014–2020. Stockholm
ECDC (2017) European centre for disease prevention and control. European surveillance of Clostridium difficile infections. Surveillance protocol version 2.3. Stockholm
Eyre DW, Walker AS (2013) Clostridium difficile surveillance: harnessing new technologies to control transmission. Expert Rev Anti-Infect Ther 11(11):1193–1205. https://doi.org/10.1586/14787210.2013.845987
Eyre DW, Fawley WN, Best EL et al (2013) Comparison of multilocus variable-number tandem-repeat analysis and whole-genome sequencing for investigation of Clostridium difficile transmission. J Clin Microbiol 51(12):4141–4149. https://doi.org/10.1128/JCM.01095-13
Fawley WN, Wilcox MH, Clostridium difficile Ribotyping Network for E et al (2011) An enhanced DNA fingerprinting service to investigate potential Clostridium difficile infection case clusters sharing the same PCR ribotype. J Clin Microbiol 49(12):4333–4337. https://doi.org/10.1128/JCM.05873-11
Freeman J, Bauer MP, Baines SD et al (2010) The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 23(3):529–549. https://doi.org/10.1128/CMR.00082-09
Goorhuis A, Bakker D, Corver J et al (2008) Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47(9):1162–1170. https://doi.org/10.1086/592257
He M, Miyajima F, Roberts P et al (2013) Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 45(1):109–113. https://doi.org/10.1038/ng.2478
Healthcare Commission (2006) Investigation into outbreaks of Clostridium difficile at Stoke Mandeville Hospital. Trust, Buckinghamshire Hospitals NHS
Health Protection Scotland (2006) CDI background. http://www.hps.scot.nhs.uk/resourcedocument.aspx?resourceid=1446
Health Protection Scotland (2009) Guidance on Prevention and Control of Clostridium difficile Infection (CDI) in Healthcare Settings in Scotland. Health Protection Network Scottish Guidance 6. Health Protection Scotland. http://www.processcleaningsolutions.com/pdf/clostridium-difficile-infection-guidelines%20Scotland.pdf
Health Protection Scotland (2010) The annual surveillance of healthcare associated infection report January – December 2009. http://www.documents.hps.scot.nhs.uk/hai/annual-report/annual-surveillance-haireport-2009.pdf
Health Protection Scotland (2012) The annual surveillance of healthcare associated infections report. January–December 2011. http://www.documents.hps.scot.nhs.uk/hai/annual-report/annual-surveillance-haireport-2011.pdf
Health Protection Scotland (2014) Prevention and Control of Clostridium difficile (CDI) in care settings in Scotland. 2.1
Kelly CP, LaMont JT (1998) Clostridium difficile infection. Annu Rev Med 49:375–390. https://doi.org/10.1146/annurev.med.49.1.375
Kola A, Wiuff C, Akerlund T et al (2016) Survey of Clostridium difficile infection surveillance systems in Europe, 2011. Euro Surveill 21(29). https://doi.org/10.2807/1560-7917.es.2016.21.29.30291
Kuijper EJ, Coignard B, Tull P (2006) Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 12(6):2–18. https://doi.org/10.1111/j.1469-0691.2006.01580.x
Kuijper EJ, Coignard B, Brazier JS et al (2007) Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe. Euro Surveill 12(6):E1–E2
Kuijper EJ, Barbut F, Brazier JS et al (2008) Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 13(31):pii: 18942
Lawes T, Lopez-Lozano JM, Nebot CA et al (2017) Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: anon-linear time-series analysis. Lancet Infect Dis 17(2):194–206. https://doi.org/10.1016/S1473-3099(16)30397-8
McDonald LC, Coignard B, Dubberke E et al (2007) Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 28(2):140–145. https://doi.org/10.1086/511798
Nathwani D, Sneddon J, Malcolm W et al (2011) Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme. Int J Antimicrob Agents 38(1):16–26. https://doi.org/10.1016/j.ijantimicag.2011.02.005
Pearson A (2009) Historical and changing epidemiology of healthcare-associated infections. J Hosp Infect 73(4):296–304. https://doi.org/10.1016/j.jhin.2009.08.016
Ricciardi R, Rothenberger DA, Madoff RD et al (2007) Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 142(7):624–631. https://doi.org/10.1001/archsurg.142.7.624. discussion 631
Scottish Government (2012) NHSScotland local delivery plan guidance 2013/14
The Vale of Leven Hospital Inquiry (2014) The Vale of Leven Hospital inquiry report. The Rt Hon Lord MacLean
van Dorp SM, Kinross P, Gastmeier P et al (2016a) Standardised surveillance of Clostridium difficile infection in European acute care hospitals: a pilot study, 2013. Euro Surveill 21(29). https://doi.org/10.2807/1560-7917.es.2016.21.29.30293
van Dorp SM, Notermans DW, Alblas J et al (2016b) Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014. Euro Surveill 21(29). https://doi.org/10.2807/1560-7917.es.2016.21.29.30292
Vonberg RP, Kuijper EJ, Wilcox MH et al (2008) Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect 14(Suppl 5):2–20. https://doi.org/10.1111/j.1469-0691.2008.01992.x
Warny M, Pepin J, Fang A et al (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366(9491):1079–1084. https://doi.org/10.1016/S0140-6736(05)67420-X
Wilcox MH, Mooney L, Bendall R et al (2008) A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 62(2):388–396. https://doi.org/10.1093/jac/dkn163
Wilcox MH, Shetty N, Fawley WN et al (2012) Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin Infect Dis 55(8):1056–1063. https://doi.org/10.1093/cid/cis614
Wiuff C, Brown DJ, Mather H et al (2011) The epidemiology of Clostridium difficile in Scotland. J Inf Secur 62(4):271–279. https://doi.org/10.1016/j.jinf.2011.01.015
Wiuff C, Banks A, Brown DJ, Henderson D,Coia JE, Inkster T (2014) The changing epidemiology of Clostridium difficile ribotypes in Scotland between 2009 and 2013. Paper presented at the European Congress on Clinical Microbiology and Infectious Diseases, 2014, Barcelona
World Bank (2017) GNI (nominal) per capita for year 2016, World Development Indicators database, Atlas method, World Bank, revised 01 July 2017
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Wiuff, C., Banks, AL., Fitzpatrick, F., Cottom, L. (2018). The Need for European Surveillance of CDI. In: Mastrantonio, P., Rupnik, M. (eds) Updates on Clostridium difficile in Europe. Advances in Experimental Medicine and Biology(), vol 1050. Springer, Cham. https://doi.org/10.1007/978-3-319-72799-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-72799-8_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-72798-1
Online ISBN: 978-3-319-72799-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)